The National Institutes of Health unveiled two new grant programs this week for small research companies that will be supported by stimulus funds provided to the NIH under the American Recovery & Reinvestment Act of 2009. “These new programs will help provide much-needed resources to biotech companies, who are at the cusp of many medical [...]
Filed under: BIO, Uncategorized | Tagged: BIO, financing, NIH, Small Business | Leave a Comment »
Is your life sciences company led by women?
Springboard Enterprises is looking for women-led science companies to present at AllThingsLifeSciences 2009 — a venture forum showcasing early and later stage biotech, medical device, health care IT, products & services and other life science companies.
According to Venture-Catalyst Springboard Enterprises, it is
“the go-to organization for information about and [...]
Filed under: venture capital | Tagged: VC | Leave a Comment »
A two-time cancer survivor and a perennial Republican swing voter, Senator Arlen Specter (R-PA), urged the creation of the Cures Acceleration Network, a new agency to provide grants to help biotech companies develop new treatments, reports Reuters and The Boston Globe:
I believe that we can live not only longer lives, but healthier lives, by harnessing [...]
Filed under: Congress, Finding Cures, In the News, Uncategorized | Tagged: Cures Acceleration Network, Specter | Leave a Comment »
Josh Green, general partner at MDV-Mohr Davidow Ventures and three entrepreneurs visited Capitol Hill on Wednesday to testify before the House Small Business Committee about the need to reauthorize the SBIR program.
The Wall Street Journal’s Venture Capital Dispatch blog reported,
“Companies receiving venture funding may have other innovation in the pipeline worth [...]
Filed under: Congress, In the News, SBIR, Uncategorized | Tagged: Congress, House Small Business Committee, SBIR, venture capital | 1 Comment »
A new regional investor angel fund has sprouted up in the New England area — Mass Medical Angels (MA2) is devoting all of its funds to backing life science startups. The group says its focus is on early stage life science companies looking to raise $250K to $3.0M.
According to the group’s website
Depending on the amount [...]
Filed under: SBIR, venture capital | Tagged: biotech, venture capital | Leave a Comment »
The economic news this week wasn’t all doom and gloom – Google announced Google Ventures, a new venture capital fund that will finance biotechnology start ups, among other things.
According to Google Blog:
At its core, Google Ventures is charged with finding and helping to develop exceptional start-ups. We’ll be focusing on early stage investments across [...]
Filed under: BIO, In the News, venture capital | Tagged: biotechnology, Google, Innovation, start-up, VC, venture capital | Leave a Comment »
Today we have a guest blogger. Welcome Afif Ghannoum!
In these trying economic times, biotech entrepreneurs are being put to the test to not only raise capital, but just to survive. Start-ups that a year or two ago would have been flush with capital from several sources, have been forced to closely monitor their burn rates [...]
Filed under: Congress, venture capital | Tagged: biotech, economy, entrepreneuer, SBIR, venture capitalist | 3 Comments »
Following the conclusion to a dramatic election season, BIO President and CEO Jim Greenwood offered his congratulations to President-Elect Barack Obama.
Recognizing the challenges that the next President will face Greenwood stated in a release yesterday:
From health care to energy to climate change to environmental sustainability, President-elect Obama will enter office facing a daunting [...]
Filed under: Uncategorized | 1 Comment »
Canopy Group announces the launch of BizCafé, a unique website matching life science and high tech entrepreneurs with business opportunities, at www.IndianaBizCafe.com. The BizCafé automatically matches entrepreneurs, investors, and industry experts with opportunities and each other. The BizCafé is a one-stop shop for SBIR/STTR grants and federal procurement; it captures 99% of all available feeds, [...]
Filed under: In the News, venture capital | Leave a Comment »
